BACKGROUND: Macrophage migration inhibitory factor (MIF) exerts a protective effect on ischemic myocardium by activating AMP-activated protein kinase (AMPK). Small molecules that increase the affinity of MIF for its receptor have been recently designed, and we hypothesized that such agonists may enhance AMPK activation and limit ischemic tissue injury. METHODS AND RESULTS: Treatment of cardiomyocytes with the candidate MIF agonist, MIF20, augmented AMPK phosphorylation, increased by 50% the surface localization of glucose transporter, and enhanced by 25% cellular glucose uptake in comparison with MIF alone. In mouse hearts perfused with MIF20 before no-flow ischemia and reperfusion, postischemic left ventricular function improved commensurately with an increase in cardiac MIF-AMPK activation and an augmentation in myocardial glucose uptake. By contrast, small-molecule MIF agonism was not effective in cells or tissues genetically deficient in MIF or the MIF receptor, verifying the specificity of MIF20 for MIF-dependent AMPK signaling. The protective effect of MIF20 also was evident in an in vivo regional ischemia model. Mice treated with MIF20 followed by left coronary artery occlusion and reperfusion showed a significant reduction in infarcted myocardium. CONCLUSIONS: These data support the pharmacological utility of small-molecule MIF agonists in enhancing AMPK activation and reducing cardiac ischemic injury.
BACKGROUND:Macrophage migration inhibitory factor (MIF) exerts a protective effect on ischemic myocardium by activating AMP-activated protein kinase (AMPK). Small molecules that increase the affinity of MIF for its receptor have been recently designed, and we hypothesized that such agonists may enhance AMPK activation and limit ischemic tissue injury. METHODS AND RESULTS: Treatment of cardiomyocytes with the candidate MIF agonist, MIF20, augmented AMPK phosphorylation, increased by 50% the surface localization of glucose transporter, and enhanced by 25% cellular glucose uptake in comparison with MIF alone. In mouse hearts perfused with MIF20 before no-flow ischemia and reperfusion, postischemic left ventricular function improved commensurately with an increase in cardiac MIF-AMPK activation and an augmentation in myocardial glucose uptake. By contrast, small-molecule MIF agonism was not effective in cells or tissues genetically deficient in MIF or the MIF receptor, verifying the specificity of MIF20 for MIF-dependent AMPK signaling. The protective effect of MIF20 also was evident in an in vivo regional ischemia model. Mice treated with MIF20 followed by left coronary artery occlusion and reperfusion showed a significant reduction in infarcted myocardium. CONCLUSIONS: These data support the pharmacological utility of small-molecule MIF agonists in enhancing AMPK activation and reducing cardiac ischemic injury.
Authors: Jodi B Lubetsky; Angeles Dios; Jialian Han; Bayan Aljabari; Bela Ruzsicska; Robert Mitchell; Elias Lolis; Yousef Al-Abed Journal: J Biol Chem Date: 2002-05-07 Impact factor: 5.157
Authors: R Kleemann; A Hausser; G Geiger; R Mischke; A Burger-Kentischer; O Flieger; F J Johannes; T Roger; T Calandra; A Kapurniotu; M Grell; D Finkelmeier; H Brunner; J Bernhagen Journal: Nature Date: 2000-11-09 Impact factor: 49.962
Authors: Raymond R Russell; Ji Li; David L Coven; Marc Pypaert; Christoph Zechner; Monica Palmeri; Frank J Giordano; James Mu; Morris J Birnbaum; Lawrence H Young Journal: J Clin Invest Date: 2004-08 Impact factor: 14.808
Authors: Lin Leng; Christine N Metz; Yan Fang; Jing Xu; Seamas Donnelly; John Baugh; Thomas Delohery; Yibang Chen; Robert A Mitchell; Richard Bucala Journal: J Exp Med Date: 2003-06-02 Impact factor: 14.307
Authors: Lin Wang; Nanhu Quan; Wanqing Sun; Xu Chen; Courtney Cates; Thomas Rousselle; Xinchun Zhou; Xuezhong Zhao; Ji Li Journal: Cardiovasc Res Date: 2018-05-01 Impact factor: 10.787
Authors: Sonja Djudjaj; Ina V Martin; Eva M Buhl; Nina J Nothofer; Lin Leng; Marta Piecychna; Jürgen Floege; Jürgen Bernhagen; Richard Bucala; Peter Boor Journal: J Am Soc Nephrol Date: 2017-08-11 Impact factor: 10.121
Authors: Courtney Cates; Thomas Rousselle; Jinli Wang; Nanhu Quan; Lin Wang; Xu Chen; Likui Yang; Alireza R Rezaie; Ji Li Journal: Biochem Biophys Res Commun Date: 2017-12-27 Impact factor: 3.575
Authors: Xu Chen; Xuan Li; Wenyan Zhang; Jie He; Bo Xu; Bin Lei; Zhenhua Wang; Courtney Cates; Thomas Rousselle; Ji Li Journal: Metabolism Date: 2018-03-09 Impact factor: 8.694